Baricitinib – UPSC Prelims

Baricitinib:
  • It is part of a class of drugs called Janus kinase(JAK) inhibitors that suppress the overstimulation of the immune system.
  • It isĀ used to treat rheumatoid arthritis.
  • Now, it has been strongly recommended for patients with severe or critical Covid-19 in combination with corticosteroids.
Scroll to Top